The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion

被引:73
作者
Kim, Nayoung
Saudemont, Aurore
Webb, Louise
Camps, Montserrat
Ruckle, Thomas
Hirsch, Emilio
Turner, Martin
Colucci, Francesco [1 ]
机构
[1] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England
[2] Merck Serono Res Ctr, Geneva, Switzerland
[3] Ctr Mol Biotechnol, Dipartimento Genet Biol & Biochim, Turin, Italy
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
D O I
10.1182/blood-2007-02-075366
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The signal transduction pathways that lead activated natural killer (NK) cells to produce cytokines, releases cytotoxic granules, or do both, are not clearly dissected. For example, phosphoinositide 3-kinases (PI3Ks) are key players in the execution of both functions, but the relative contribution of each isoform is unknown. We show here that the catalytic isoform p110 delta, not p110 gamma, was required for interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), and granulocyte macrophage colony-stimulating factor (GMCSF) secretion, whereas neither was necessary for cytotoxicity. Yet, when both p110 delta and p110 gamma isoforms were inactivated by a combination of genetic and biochemical approaches, cytotoxicity was decreased. NK-cell numbers were also affected by the lack of p110 delta but not p110 gamma and more severely so in mice lacking both subunits. These results provide genetic evidence that p110 delta is the dominant PI3K isoform for cytokine secretion by NK cells and suggest that PI3Ks cooperate during NK-cell development and cytotoxicity.
引用
收藏
页码:3202 / 3208
页数:7
相关论文
共 45 条
[21]   Licensing of natural killer cells by host major histocompatibility complex class I molecules [J].
Kim, S ;
Poursine-Laurent, J ;
Truscott, SM ;
Lybarger, L ;
Song, YJ ;
Yang, LP ;
French, AR ;
Sunwoo, JB ;
Lemieux, S ;
Hansen, TH ;
Yokoyama, WM .
NATURE, 2005, 436 (7051) :709-713
[22]   Cytokines and immunodeficiency diseases:: critical roles of the γc-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways [J].
Kovanen, PE ;
Leonard, WJ .
IMMUNOLOGICAL REVIEWS, 2004, 202 :67-83
[23]   The role of PI3K in immune cells [J].
Koyasu, S .
NATURE IMMUNOLOGY, 2003, 4 (04) :313-319
[24]   Inhibition of phosphoinositide 3-kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model [J].
Lee, Kyung S. ;
Lee, Ho K. ;
Hayflick, Joel S. ;
Lee, Yong C. ;
Puri, Kamal D. .
FASEB JOURNAL, 2006, 20 (03) :455-465
[25]   Compound heterozygosity for Pten and SHIP augments T-dependent humoral immune responses and cytokine production by CD4+ T cells [J].
Moody, JL ;
Jirik, FR .
IMMUNOLOGY, 2004, 112 (03) :404-412
[26]   Inducible costimulator costimulates cytotoxic activity and IFN-γ production in activated murine NK cells [J].
Ogasawara, K ;
Yoshinaga, SK ;
Lanier, LL .
JOURNAL OF IMMUNOLOGY, 2002, 169 (07) :3676-3685
[27]   PI3K in lymphocyte development, differentiation and activation [J].
Okkenhaug, K ;
Vanhaesebroeck, B .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (04) :317-330
[28]  
Okkenhaug K, 2002, SCIENCE, V297, P1031
[29]   The p110δ isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells [J].
Okkenhaug, Klaus ;
Patton, Daniel T. ;
Bilancio, Antonio ;
Garcon, Fabien ;
Rowan, Wendy C. ;
Vanhaesebroeck, Bart .
JOURNAL OF IMMUNOLOGY, 2006, 177 (08) :5122-5128
[30]   MHC class I molecules and KIRs in human history, health and survival [J].
Parham, P .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (03) :201-214